A Mutant Type 2 Herpes Simplex Virus Deleted for the Protein Kinase Domain of the ICP10 Gene Is a Potent Oncolytic Virus-Reference-Cited by-同舟云学术

A Mutant Type 2 Herpes Simplex Virus Deleted for the Protein Kinase Domain of the ICP10 Gene Is a Potent Oncolytic Virus

Published:2006-05 Issue:5 Volume:13 Page:882-890
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Fu Xinping,Tao Lihua,Cai Rong,Prigge Jonathan,Zhang Xiaoliu

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference44 articles.

1. Experimental therapy of human glioma by means of a genetically engineered virus mutant;Martuza;Science,1991

2. Treatment of experimental intracranial murine melanoma with a neuroattenuated herpes simplex virus 1 mutant;Randazzo;Virology,1995

3. The application of genetically engineered herpes simplex viruses to the treatment of experimental brain tumors;Andreansky;Proc. Natl. Acad. Sci. USA,1996

4. Treatment of malignant gliomas using ganciclovir-hypersensitive, ribonucleotide reductase-deficient herpes simplex viral mutant;Mineta;Cancer Res.,1994

5. Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas;Mineta;Nat. Med.,1995

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress of oncolytic virotherapy for neuroblastoma;Frontiers in Pediatrics;2022-11-18

2. A novel cocktail therapy based on quintuplet combination of oncolytic herpes simplex virus-2 vectors armed with interleukin-12, interleukin-15, GM-CSF, PD1v, and IL-7 × CCL19 results in enhanced antitumor efficacy;Virology Journal;2022-04-22

3. A chimeric virus-based probe unambiguously detects live circulating tumor cells with high specificity and sensitivity;Molecular Therapy - Methods & Clinical Development;2021-12

4. Single-cell RNA sequencing reveals a strong connection between Gadd45g upregulation and oncolytic HSV infection in tumor tissue;Molecular Therapy - Oncolytics;2021-12

5. Comprehensive characterization of tumor immune landscape following oncolytic virotherapy by single-cell RNA sequencing;Cancer Immunology, Immunotherapy;2021-10-30